Table 2 Summary of factors influencing patient placement within Figure 3
From: Augmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approach
Parameter | Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 |
|---|---|---|---|---|
Age | 60+ | 50-60 | 40-50 | 30-40 |
FEV1/Kco (% pred) | >80 | 60-80 | 40-60 | 30-40 |
FEV1/Kco decline (% pred/yr) | <0.1 | 0.1-0.5 | 0.5-1.0 | >1.0 |